Ozempic: Beyond Weight Loss, It May Safeguard Brain Health – New Research Uncovers Unexpected Advantages

Ozempic: Beyond Weight Loss, It May Safeguard Brain Health – New Research Uncovers Unexpected Advantages

8 days ago | 5 Views

Ozempic has become a prominent topic of discussion, and if you are not familiar with it, you may be quite out of touch. Although this medication is primarily recognized for its remarkable weight loss effects, its advantages extend beyond that. Recent research, including two studies released today, suggests that Ozempic and other GLP-1 medications may also contribute positively to brain health. These studies indicate a notable association between these drugs and a decreased likelihood of developing dementia.

Can ozempic help prevent Alzheimer’s?

 There is currently no cure for Alzheimer's disease, which affects approximately 6.7 million Americans aged 65 and older. Nevertheless, researchers involved in recent studies are optimistic that GLP-1 medications, such as Ozempic, could eventually serve as a preventive measure against this condition. This possibility contributes to a growing array of health concerns that these drugs have demonstrated potential in addressing, including colorectal cancer, polycystic ovary syndrome (PCOS), and substance use disorders.

Diabetes drugs like ozempic linked to lower Alzheimer's risk, new studies reveal.

A recent study published in JAMA Neurology on April 7 revealed that individuals with type 2 diabetes who were treated with medications such as Ozempic, Trulicity, or Victoza experienced a reduced risk of developing Alzheimer’s disease and other forms of dementia. Dr. Jingchuan Guo, one of the researchers involved, noted that similar advantages were observed with other diabetes medications, including Jardiance and Farxiga.

What the studies found

 Dr. Jingchuan Guo expressed enthusiasm regarding the potential of diabetes medications to also safeguard brain health. He underscored the importance of comprehending how these drugs function in practical, everyday scenarios as their usage becomes more widespread.

A significant analysis published in JAMA Neurology on April 7, which examined 26 studies involving over 160,000 participants, revealed comparable findings, indicating that GLP-1 medications were associated with a 45% reduction in the risk of dementia. Co-author Dr. Catriona Reddin described this as a pivotal advancement in understanding how diabetes therapies may contribute to brain health.

Dr. Jingchuan Guo pointed out that although diabetes has historically been associated with an increased risk of dementia, it remained uncertain whether blood sugar-lowering medications could effectively prevent cognitive decline. “Our findings indicate that GLP-1 receptor agonists, in particular, are linked to a decreased risk of dementia,” she stated.

Can they help non-diabetics too?

Both Research has primarily concentrated on individuals with type 2 diabetes, largely due to the data being sourced from 2014, a period when these medications were predominantly prescribed to diabetic patients. Guo noted that while several newer GLP-1 medications have recently received approval for weight management, their application for treating obesity is still in its early stages.

Diabetes medications show promise in lowering Alzheimer's risk, researchers say.

Individuals with diabetes have an increased risk of developing Alzheimer’s disease, partly due to the damaging effects of elevated blood sugar levels on the brain's blood vessels, which can lead to inflammation—a condition also associated with obesity. Neuroinflammation, or inflammation within the nervous system, is frequently observed in patients with Alzheimer’s.

Dr. Guo emphasized that the next significant step is to investigate the impact of these medications on individuals without type 2 diabetes. Both researchers see substantial potential for GLP-1 drugs to serve as a preventive measure against Alzheimer’s in the future. However, they concur that more focused research is essential. “It’s possible they may help prevent Alzheimer’s one day,” stated Dr. Reddin, “but we require extensive trials specifically examining how these drugs influence cognitive health.”

Read Also: New Study: Boredom Hunger Can Trick Your Body and Immune System

"Get the latest Bollywood entertainment news, trending celebrity news, latest celebrity news, new movie reviews, latest entertainment news, latest Bollywood news, and Bollywood celebrity fashion & style updates!"

HOW DID YOU LIKE THIS ARTICLE? CHOOSE YOUR EMOTICON!
#